Subsequently, both univariate and multivariate analyses indicated that PGAP3 and ERBB2 were independent prognostic factors for patients with GC (PGAP3: *p = 0.013 and *p = 0.042; ERBB2: **p = 0.008 and *p = 0.033). This evidence concerns the gene PGAP3 and gastric cancer.